Arbela Laboratories, Inc.
About Arbela Laboratories, Inc.
Arbela Laboratories, Inc. develops sustainable nutrition products using a novel strain of yeast called Pichia pastoris, which is rich in protein, fiber, and beta glucan. The company's advanced processing technology enables large-scale, affordable production supporting human and animal health with net-zero greenhouse gas emissions, minimal land or water use, and no fertilizers or pesticides. Its focus addresses dietary deficiencies linked to chronic diseases by restoring fiber in processed foods.
- 🔗 Arbela Labs Stock Price, Funding, Valuation, Revenue & Financial Statements
- 🔗 Arbela - 2026 Company Profile, Team & Competitors - Tracxn
- 🔗 Arbela
- 🔗 Liberation Labs bags $25m to fund Indiana biomanufacturing hub
- 🔗 Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised $0.58M in an Unattributed round in April 2024.
- Total funding stands at $650K across two rounds including one grant.
- Technology centers on Pichia pastoris yeast for net-zero nutrition production.
- Targets gut health and fiber deficiencies in processed foods.
- Operates with minimal resource inputs and no agricultural land use.
Ask StreetZero about Arbela Laboratories, Inc.
Put our AI to work on this deal.
Similar companies
Other Crowdfunding deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account